Acclinate is a series a startup. 1 investor tracked. Status: possibledead.
Acclinate is a startup based in the United States. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Acclinate is a genetics company that offers DNA-based carrier screening tests to help individuals and couples understand their genetic risks for inherited conditions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.